---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295711892.md"
description: "Corbus Pharmaceuticals Holdings Inc. (CRBP) shares rose 2.63% to $9.76 on Wednesday, marking a second consecutive day of gains. However, the stock underperformed relative to competitors like Vanda Pharmaceuticals and Fortress Biotech during a mixed trading session where the NASDAQ Composite Index rose 0.54%. CRBP remains 52.53% below its 52-week high of $20.56."
datetime: "2026-08-12T21:21:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295711892.md)
  - [en](https://longbridge.com/en/news/295711892.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295711892.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) rose 2.63% to $9.76 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.54% to 26,588.49 and the Dow Jones Industrial Average falling 0.04% to 53,770.27.

This was the stock's second consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 52.53% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 5.27% to $5.19, Fortress Biotech Inc. (FBIO) rose 5.36% to $2.75, and Viking Therapeutics Inc. (VKTX) rose 0.65% to $34.02.

Data source: Dow Jones Market Data, FactSet. Data compiled August 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-12-26 1721ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [Corbus Pharma CFO Sean Moran sells 12,000 shares for $120,971](https://longbridge.com/en/news/295447150.md)
- [Corbus Pharma CMO Nicacio Leonardo Viana files initial beneficial ownership statement](https://longbridge.com/en/news/294867785.md)
- [Corbus says Phase 1b CANYON-1 obesity trial of CRB-913 reaches last patient last visit](https://longbridge.com/en/news/294824963.md)
- [Corbus Chief Business Officer Nishant Saxena acquires 2,600 shares worth $25,037.44](https://longbridge.com/en/news/295706183.md)
- [Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market](https://longbridge.com/en/news/294418522.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**